JP2024520654A5 - - Google Patents
Info
- Publication number
- JP2024520654A5 JP2024520654A5 JP2023574412A JP2023574412A JP2024520654A5 JP 2024520654 A5 JP2024520654 A5 JP 2024520654A5 JP 2023574412 A JP2023574412 A JP 2023574412A JP 2023574412 A JP2023574412 A JP 2023574412A JP 2024520654 A5 JP2024520654 A5 JP 2024520654A5
- Authority
- JP
- Japan
- Prior art keywords
- independently selected
- cycloalkyl
- alkyl
- membered
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163196422P | 2021-06-03 | 2021-06-03 | |
| US63/196,422 | 2021-06-03 | ||
| PCT/IB2022/055131 WO2022254362A1 (en) | 2021-06-03 | 2022-06-01 | 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and medical uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024520654A JP2024520654A (ja) | 2024-05-24 |
| JP2024520654A5 true JP2024520654A5 (https=) | 2025-05-30 |
Family
ID=82115547
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023574412A Pending JP2024520654A (ja) | 2021-06-03 | 2022-06-01 | ３－（１－オキソイソインドリン－２－イル）ピペリジン－２，６－ジオン誘導体及びその医療用使用 |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US12103919B2 (https=) |
| EP (1) | EP4347580A1 (https=) |
| JP (1) | JP2024520654A (https=) |
| KR (1) | KR20240013812A (https=) |
| CN (1) | CN117062811A (https=) |
| AR (1) | AR126052A1 (https=) |
| AU (1) | AU2022284366A1 (https=) |
| BR (1) | BR112023024905A2 (https=) |
| CA (1) | CA3215410A1 (https=) |
| CL (1) | CL2023003561A1 (https=) |
| CO (1) | CO2024000013A2 (https=) |
| CR (1) | CR20230614A (https=) |
| DO (1) | DOP2023000261A (https=) |
| EC (1) | ECSP24000004A (https=) |
| IL (1) | IL308094A (https=) |
| JO (1) | JOP20230308A1 (https=) |
| MX (1) | MX2023014327A (https=) |
| PE (1) | PE20240657A1 (https=) |
| PY (1) | PY2243958A (https=) |
| TW (1) | TW202306570A (https=) |
| UY (1) | UY39796A (https=) |
| WO (1) | WO2022254362A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12122764B2 (en) * | 2021-12-22 | 2024-10-22 | Gilead Sciences, Inc. | IKAROS zinc finger family degraders and uses thereof |
| WO2023178181A1 (en) | 2022-03-17 | 2023-09-21 | Gilead Sciences, Inc. | Ikaros zinc finger family degraders and uses thereof |
| EP4612128A4 (en) | 2022-11-04 | 2025-09-10 | Bristol Myers Squibb Co | COMPOUNDS AND THEIR USE FOR THE TREATMENT OF HEMOGLOBINOPATHIES |
| WO2025230875A1 (en) * | 2024-04-29 | 2025-11-06 | Bristol-Myers Squibb Company | Compounds and their use for treatment of hemoglobinopathies |
| CN118598797A (zh) * | 2024-05-17 | 2024-09-06 | 诚达药业股份有限公司 | 一种手性3-羟基-4-氟哌啶衍生物的合成方法及拆分方法 |
| WO2026002044A1 (zh) * | 2024-06-25 | 2026-01-02 | 标新生物医药科技(上海)有限公司 | 含有硫/氧取代戊二酰亚胺基异吲哚啉酮骨架的双功能蛋白降解剂及它们的应用 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007524596A (ja) | 2003-02-28 | 2007-08-30 | トランスフォーム・ファーマシューティカルズ・インコーポレイテッド | 共結晶医薬組成物 |
| PL3202460T3 (pl) | 2010-02-11 | 2019-12-31 | Celgene Corporation | Pochodne arylometoksyizoindoliny i zawierające je kompozycje oraz sposoby ich zastosowania |
| WO2012068512A1 (en) | 2010-11-18 | 2012-05-24 | Deuteria Pharmaceuticals Llc | 3-deutero-pomalidomide |
| WO2012079022A1 (en) | 2010-12-10 | 2012-06-14 | Concert Pharmaceuticals, Inc. | Substituted dioxopiperidinyl phthalimide derivatives |
| US9133161B2 (en) | 2012-07-27 | 2015-09-15 | Celgene Corporation | Processes for preparing isoindoline-1,3-dione compounds |
| WO2017024019A1 (en) | 2015-08-04 | 2017-02-09 | Celgene Corporation | Methods for treating chronic lymphocytic leukemia and the use of biomarkers as a predictor of clinical sensitivity to immunomodulatory therapies |
| EP3445765A4 (en) | 2016-04-22 | 2019-09-18 | Dana Farber Cancer Institute, Inc. | DECREASE OF CYCLINE-DEPENDENT KINASE 4/6 (CDK4 / 6) BY CONJUGATION OF CDK4 / 6 INHIBITORS WITH E3-LIGASE LIGANDS AND METHODS OF USE |
| CN110506039A (zh) | 2016-10-11 | 2019-11-26 | 阿尔维纳斯股份有限公司 | 用于雄激素受体靶向降解的化合物和方法 |
| MX2019005007A (es) | 2016-11-01 | 2019-07-18 | Arvinas Inc | Protac dirigidos a la proteína tau y métodos asociados de uso. |
| BR112019011200B1 (pt) | 2016-12-01 | 2021-12-28 | Arvinas Operations, Inc | Derivados de tetrahidronaftaleno e tetrahidroisoquinolina como degradadores do receptor de estrogênio |
| JP2020505327A (ja) | 2016-12-23 | 2020-02-20 | アルビナス・オペレーションズ・インコーポレイテッドＡｒｖｉｎａｓ Ｏｐｅｒａｔｉｏｎｓ， Ｉｎｃ． | Ｅｇｆｒタンパク質分解標的化キメラ分子およびその関連する使用方法 |
| KR20250117470A (ko) | 2016-12-23 | 2025-08-04 | 아비나스 오퍼레이션스, 인코포레이티드 | 급속 진행성 섬유육종 폴리펩티드의 표적화 분해를 위한 화합물 및 방법 |
| US10806737B2 (en) | 2016-12-23 | 2020-10-20 | Arvinas Operations, Inc. | Compounds and methods for the targeted degradation of fetal liver kinase polypeptides |
| US11191741B2 (en) | 2016-12-24 | 2021-12-07 | Arvinas Operations, Inc. | Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide |
| BR112019015312A2 (pt) | 2017-01-26 | 2020-03-10 | Arvinas Operations, Inc. | Moduladores da proteólise pelo receptor de estrogênio e métodos de uso associados |
| AU2018351050B2 (en) | 2017-10-18 | 2025-09-18 | Novartis Ag | Compositions and methods for selective protein degradation |
| WO2019079701A1 (en) | 2017-10-20 | 2019-04-25 | Dana-Farber Cancer Institute, Inc. | HETEROBIFUNCTIONAL COMPOUNDS HAVING IMPROVED SPECIFICITY FOR BRD4 BROMODOMAINE |
| EP3710443A1 (en) | 2017-11-17 | 2020-09-23 | Arvinas Operations, Inc. | Compounds and methods for the targeted degradation of interleukin-1 receptor-associated kinase 4 polypeptides |
| IL315310A (en) | 2017-12-26 | 2024-10-01 | Kymera Therapeutics Inc | Irak degraders and uses thereof |
| EP3765026A4 (en) | 2018-03-10 | 2021-12-22 | Yale University | BTK PROTEOLYSIS MODULATORS AND METHODS FOR USE |
| WO2019195609A2 (en) | 2018-04-04 | 2019-10-10 | Arvinas Operations, Inc. | Modulators of proteolysis and associated methods of use |
| AU2019294835B2 (en) | 2018-06-29 | 2025-04-17 | Dana-Farber Cancer Institute, Inc. | Ligands to cereblon (CRBN) |
| US12030892B2 (en) | 2018-06-29 | 2024-07-09 | Dana-Farber Cancer Institute, Inc. | CRBN modulators |
| EP3814330A4 (en) | 2018-06-29 | 2022-07-20 | Dana-Farber Cancer Institute, Inc. | Immunomodulatory compounds |
| US12060366B2 (en) | 2018-06-29 | 2024-08-13 | Dana-Farber Cancer Institute, Inc. | Bispecific degraders |
| BR122022012697B1 (pt) * | 2018-07-10 | 2023-04-04 | Novartis Ag | Usos de derivados de 3-(5-hidróxi-1-oxoisoindolin-2-il)piperidina-2,6- diona, e kit |
| AU2019391016B2 (en) * | 2018-12-03 | 2025-05-29 | Dana-Farber Cancer Institute, Inc. | Small molecule degraders of helios and methods of use |
| WO2021053555A1 (en) | 2019-09-16 | 2021-03-25 | Novartis Ag | Glue degraders and methods of use thereof |
| CA3154386A1 (en) * | 2019-10-17 | 2021-04-22 | Michael Berlin | Bifunctional molecules containing an e3 ubiquitine ligase binding moiety linked to a bcl6 targeting moiety |
| PH12022551482A1 (en) | 2019-12-18 | 2023-11-29 | Novartis Ag | 3-(5-methoxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof |
-
2022
- 2022-06-01 WO PCT/IB2022/055131 patent/WO2022254362A1/en not_active Ceased
- 2022-06-01 CN CN202280022964.9A patent/CN117062811A/zh active Pending
- 2022-06-01 BR BR112023024905A patent/BR112023024905A2/pt not_active Application Discontinuation
- 2022-06-01 UY UY0001039796A patent/UY39796A/es unknown
- 2022-06-01 TW TW111120484A patent/TW202306570A/zh unknown
- 2022-06-01 KR KR1020237045016A patent/KR20240013812A/ko not_active Ceased
- 2022-06-01 EP EP22731823.5A patent/EP4347580A1/en active Pending
- 2022-06-01 IL IL308094A patent/IL308094A/en unknown
- 2022-06-01 MX MX2023014327A patent/MX2023014327A/es unknown
- 2022-06-01 AU AU2022284366A patent/AU2022284366A1/en not_active Abandoned
- 2022-06-01 CA CA3215410A patent/CA3215410A1/en active Pending
- 2022-06-01 PY PY202202243958A patent/PY2243958A/es unknown
- 2022-06-01 CR CR20230614A patent/CR20230614A/es unknown
- 2022-06-01 PE PE2023003180A patent/PE20240657A1/es unknown
- 2022-06-01 AR ARP220101454A patent/AR126052A1/es not_active Application Discontinuation
- 2022-06-01 JP JP2023574412A patent/JP2024520654A/ja active Pending
- 2022-06-01 US US17/829,933 patent/US12103919B2/en active Active
-
2023
- 2023-11-29 CL CL2023003561A patent/CL2023003561A1/es unknown
- 2023-11-29 DO DO2023000261A patent/DOP2023000261A/es unknown
- 2023-11-29 JO JOJO/P/2023/0308A patent/JOP20230308A1/ar unknown
-
2024
- 2024-01-02 CO CONC2024/0000013A patent/CO2024000013A2/es unknown
- 2024-01-02 EC ECSENADI20244A patent/ECSP24000004A/es unknown
- 2024-09-03 US US18/823,254 patent/US20250026736A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024520654A5 (https=) | ||
| EP1027363B1 (en) | Adenosine a1-receptor agonists | |
| JP2024509981A5 (https=) | ||
| RU2004106555A (ru) | Производные фенэтаноламина для лечения респираторных заболеваний | |
| RU2002123350A (ru) | Дипептиднитрильные ингибиторы катепсина К | |
| RU2004138819A (ru) | Ингибиторы протеинкиназ jak и cdk2 | |
| RU2004131641A (ru) | Новые соединения | |
| RU2008142841A (ru) | СОЕДИНЕНИЯ ИМИДАЗО-[1, 2-b]-ПИРИДАЗИНА (ВАРИАНТЫ), СПОСОБ ПОЛУЧЕНИЯ СОЕДИНЕНИЙ ИМИДАЗО-[1, 2-b]-ПИРИДАЗИНА (ВАРИАНТЫ), ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И ЛЕКАРСТВЕННОЕ СРЕДСТВО ДЛЯ ЛЕЧЕНИЯ И/ИЛИ ПРЕДУПРЕЖДЕНИЯ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С МОДУЛЯЦИЕЙ ГАМКА РЕЦЕПТОРОВ | |
| IL205501A (en) | Preparation of preparations for the treatment of arthritis | |
| RU2002135312A (ru) | Средство, усиливающие секрецию гормона роста | |
| JP2004517843A5 (https=) | ||
| IL308094A (en) | 3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND THEIR MEDICAL USES | |
| RU2007106930A (ru) | Производные хиназолина | |
| RU98119076A (ru) | Производные 2-(3h)-оксазолона и их применение в качестве ингибиторов сох-2 | |
| JP2005514370A5 (https=) | ||
| RU2007112675A (ru) | ПРОИЗВОДНЫЕ ИМИДАЗО[1,5-a]ТРИАЗОЛО[1,5-d]БЕНЗОДИАЗЕПИНА ДЛЯ ЛЕЧЕНИЯ КОГНИТИВНЫХ РАССТРОЙСТВ | |
| JP2024509625A5 (https=) | ||
| EP2175850A1 (en) | Methods for treating anxiety | |
| ZA200104269B (en) | 4,5-azolo-oxindoles. | |
| RU2002105518A (ru) | Гетероциклические соединения, ингибирующие ангиогенез | |
| JP2013540778A (ja) | 新規抗がん剤 | |
| JP2007509052A5 (https=) | ||
| EP3535239A1 (en) | Inhibitors of mtor-deptor interactions and methods of use thereof | |
| JP2006520396A5 (https=) | ||
| JP5469707B2 (ja) | 脳梗塞に関連する脳血管障害の治療に有用なピラゾロン化合物 |